ArticleArchives of medical science : AMS2025
Implications for the role of natural products in Parkinson disease therapy.
Article in Archives of medical science : AMS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Humans still suffer from several nervous system diseases affecting perception and body movement, such as Alzheimer's and Parkinson's diseases. Parkinson's disease is a globally common disease of the nervous system that is characterized by neurodegenerative movement disorders. Patients with Parkinson's disease are characterized by the slow loss of dopaminergic (DA-ergic) neurons, especially in areas of brain tissue called the substantia nigra pars compacta. However, there is still no clear evidence regarding the factors responsible for development of the disease, which remains vague. There are some indications that oxidative stress and mitochondrial dysfunction are among the main causes of the disease. Parkinson's patients are still dependent on taking levodopa as the recommended therapeutic drug. This drug, although it has many side effects, slows down the progression of the disease. Therefore, many scientists and pharmacologists are striving to find a potential drug that can halt the disease while minimizing side effects. Research is underway to find effective natural substances against Parkinson's disease that can renew the vitality of mitochondria and activate their function, as well as diminish the oxidation process in the nerve cells. Therefore, the aim of this review was to highlight the potential role of some natural products from plant sources, such as natural medicinal herbs or marine sources, in protecting neurons and improving their biological functions in order to develop new therapeutic strategies against Parkinson's disease.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.